These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24400836)

  • 1. Probing the N-terminal β-sheet conversion in the crystal structure of the human prion protein bound to a nanobody.
    Abskharon RN; Giachin G; Wohlkonig A; Soror SH; Pardon E; Legname G; Steyaert J
    J Am Chem Soc; 2014 Jan; 136(3):937-44. PubMed ID: 24400836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prion protein: Structural features and related toxic peptides.
    Ronga L; Tizzano B; Palladino P; Ragone R; Urso E; Maffia M; Ruvo M; Benedetti E; Rossi F
    Chem Biol Drug Des; 2006 Sep; 68(3):139-47. PubMed ID: 17062011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features.
    Derreumaux P
    Biophys J; 2001 Sep; 81(3):1657-65. PubMed ID: 11509378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
    Inouye H; Kirschner DA
    J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study.
    Mollica L; Giachin G
    J Chem Inf Model; 2023 Jan; 63(2):531-545. PubMed ID: 36580661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of prion inhibition by phenothiazine compounds.
    Baral PK; Swayampakula M; Rout MK; Kav NN; Spyracopoulos L; Aguzzi A; James MN
    Structure; 2014 Feb; 22(2):291-303. PubMed ID: 24373770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
    Béland M; Roucou X
    J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperonin-mediated de novo generation of prion protein aggregates.
    Stöckel J; Hartl FU
    J Mol Biol; 2001 Nov; 313(4):861-72. PubMed ID: 11697909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
    D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
    Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.
    Gabus C; Auxilien S; Péchoux C; Dormont D; Swietnicki W; Morillas M; Surewicz W; Nandi P; Darlix JL
    J Mol Biol; 2001 Apr; 307(4):1011-21. PubMed ID: 11286552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange.
    Lu X; Wintrode PL; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1510-5. PubMed ID: 17242357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.